🇺🇸 FDA
Pipeline program

Placebo

VK2735-202

Phase 2 small_molecule completed

Quick answer

Placebo for Weight Loss is a Phase 2 program (small_molecule) at Viking Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Viking Therapeutics
Indication
Weight Loss
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials